Skip to main content
Clinical Trials/NCT01181414
NCT01181414
Completed
Phase 4

Phase 4. Study of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation.

Hospital Clinic of Barcelona1 site in 1 country60 target enrollmentOctober 2010

Overview

Phase
Phase 4
Intervention
Atrio ventricular junction ablation with radio-frequency
Conditions
Chronic Heart Failure
Sponsor
Hospital Clinic of Barcelona
Enrollment
60
Locations
1
Primary Endpoint
Left ventricular reverse remodelling in cardiac resynchronization therapy and atrial fibrillation.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The aim of the present study is to compare the response to cardiac resynchronization therapy (CRT) in patients with chronic advanced heart failure and permanent atrial fibrillation (AF) depending on atrio ventricular junction (AVJ) is ablated or not.

Detailed Description

Cardiac resynchronization therapy (CRT) improves the functional capacity and the quality of life and reduces the mortality of patients with dilated cardiomyopathy, low ejection fraction and wide QRS. Only 2% of patients included in CRT randomized trials were in AF. To obtain a good response to CRT, percentage \>90% of ventricular pacing must be obtained. Based on observational studies, current guidelines of CRT recommend the atrio ventricular junction (AVJ) ablation in those patients with permanent atrial fibrillation.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
January 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Josep Lluis Mont Girbau

Head of the Arrhythmia Unit

Hospital Clinic of Barcelona

Eligibility Criteria

Inclusion Criteria

  • Dilated cardiomyopathy (LVEDD \>56 mm)
  • wide QRS (\> 120 msec)
  • NYHA III-IV
  • Permanent AF

Exclusion Criteria

  • Not provided

Arms & Interventions

Atrioventricular junction ablation

Atrioventricular junction ablation by using radiofrequency energy.

Intervention: Atrio ventricular junction ablation with radio-frequency

Drug control of ventricular rate

Drug control of ventricular rate.

Intervention: Beta blocker/digoxine/amiodarone

Outcomes

Primary Outcomes

Left ventricular reverse remodelling in cardiac resynchronization therapy and atrial fibrillation.

Time Frame: 1-year follow-up

Comparison of echocardiographic responders in patients with permanent atrial fibrillation submitted to cardiac resynchronization therapy depending on whether the atrio-ventricular junction is ablated or not. Echocardiographic response was defined as left ventricular end-systolic volume reduction \>10%.

Secondary Outcomes

  • Clinical response to Cardiac resynchronization therapy.(1-year follow-up)

Study Sites (1)

Loading locations...

Similar Trials